No Significant Effect Of Ginkgo Biloba Special Extract EGb 761 In The Treatment Of Primary Raynaud Phenomenon: A Randomized Controlled Trial

Effect None
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 41
Sex Both Genders
Age Range 18-29, 30-44
Notes for this study:
Supplementation of 240mg EGb-761 daily for a period of 10 weeks has failed to outperform placebo in reducing symptoms of Raynaud's Phenomena.

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.